undefined undefined
NaN.000
NaN.00%
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) ...
04-09 20:00
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
04-09 10:20
Gainers: Allurion Technologies (ALUR) +107%. Candel Therapeutics (CADL) +93%. TC BioPharm plc (TCBP) +62%. HWH International (HWH) +47%. Barinthus Biotherapeutics Plc. (BRNS) +41%. Eiger BioPharmaceut...
04-05 01:06
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P 500 also rose, gaining, 0.75% to 5,250.72.
04-04 23:58
Effector Therapeutics, Inc. (EFTR) has disclosed a new risk, in the Share Price...
03-27 14:01
Gainers: Stoke Therapeutics (STOK) +79%. Mesoblast ADR (MESO) +29%. ABVC BioPharma (ABVC) +31%. Praxis Precision Medicines (PRAX) +25%. Check-Cap (CHEK) +23%. Losers: NeuBase Therapeutics (NBSE) -54%....
03-26 22:00
Losers: NeuBase Therapeutics (NBSE) -58%. AppTech Payments Corp (APCX) -41% announces proposed underwritten public offering. Ampio Pharmaceuticals (AMPE) -38% announces voluntary delisting and SEC der...
03-26 20:15
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) (the "Company"), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that it has entered into a
01-25 21:11
U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell 0.66% to 14,745.96. The S&P 500 also fell, dropping, 0.55% to 4,737.17.
01-09 22:40
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that its Board of Directors (the "Board") has
01-09 21:10